Literature DB >> 26901103

The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma.

Reinhard Dummer1, Marco Siano2, Robert E Hunger3, Nicole Lindenblatt4, Ralph Braun1, Oliver Michielin5, Daniela Mihic-Probst6, Roger von Moos7, Yousef Najafi8, Merlin Guckenberger8, Andreas Arnold9.   

Abstract

Cutaneous melanoma is the most deadly cutaneous neoplasm. In order to guide treatment decisions and follow-up of melanoma patients, guidelines for the management of melanoma in Switzerland were inaugurated in 2001 and revised in 2006 and 2016. Recent data on surgical and medical treatments from randomised trials necessitated modification of the treatment and follow-up recommendations.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26901103     DOI： 10.4414/smw.2016.14279

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN： 0036-7672            Impact factor:   2.193


  12 in total

1.  Risk Factors of Subsequent Primary Melanomas in Austria.

Authors:  Christoph Müller; Judith Wendt; Sabine Rauscher; Raute Sunder-Plassmann; Erika Richtig; Ingrid Fae; Gottfried Fischer; Ichiro Okamoto
Journal:  JAMA Dermatol       Date:  2019-02-01       Impact factor: 10.282

Review 2.  Biophysical characterization of melanoma cell phenotype markers during metastatic progression.

Authors:  Anna Sobiepanek; Alessio Paone; Francesca Cutruzzolà; Tomasz Kobiela
Journal:  Eur Biophys J       Date:  2021-03-17       Impact factor: 1.733

3.  Rare nodular malignant melanoma of the heel in the Caribbean: A case report.

Authors:  Wayne A Warner; Vandana Devika Sookdeo; Srikanth Umakanthan; Kevin Sarran; Lemuel Pran; Maurice Fortuné; Wesley Greaves; Sharda Narinesingh; Dave Harnanan; Ravi Maharaj
Journal:  Int J Surg Case Rep       Date:  2016-11-27

Review 4.  How I treat metastatic melanoma.

Authors:  Reinhard Dummer; Joanna Mangana; Anna Lisa Frauchiger; Claudia Lang; Sara Micaletto; Marjam J Barysch
Journal:  ESMO Open       Date:  2019-07-21

5.  Lymph node identification in skin malignancy using indocyanine green transcutaneously study: Study protocol for a diagnostic accuracy study.

Authors:  Ioana Lese; Jonathan Ian Leckenby; Adriano Taddeo; Mihai Constantinescu; Radu Olariu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

6.  Whole-Body MRI for the Detection of Recurrence in Melanoma Patients at High Risk of Relapse.

Authors:  Yanina J L Jansen; Inneke Willekens; Teofila Seremet; Gil Awada; Julia Katharina Schwarze; Johan De Mey; Carola Brussaard; Bart Neyns
Journal:  Cancers (Basel)       Date:  2021-01-25       Impact factor: 6.639

7.  Sarcoid-like reactions in patients receiving modern melanoma treatment.

Authors:  Florentia Dimitriou; Anna L Frauchiger; Mirjana Urosevic-Maiwald; Mirjam C Naegeli; Simone M Goldinger; Marjam Barysch; Daniel Franzen; Jivko Kamarachev; Ralph Braun; Reinhard Dummer; Joanna Mangana
Journal:  Melanoma Res       Date:  2018-06       Impact factor: 3.599

Review 8.  Whole-body magnetic resonance imaging (WB-MRI) for cancer screening in asymptomatic subjects of the general population: review and recommendations.

Authors:  Fabio Zugni; Anwar Roshanali Padhani; Dow-Mu Koh; Paul Eugene Summers; Massimo Bellomi; Giuseppe Petralia
Journal:  Cancer Imaging       Date:  2020-05-11       Impact factor: 3.909

9.  Serum proteomic analysis of melanoma patients with immunohistochemical profiling of primary melanomas and cultured cells: Pilot study.

Authors:  Jan Kučera; Karolína Strnadová; Barbora Dvořánková; Lukáš Lacina; Ivana Krajsová; Jiří Štork; Hana Kovářová; Helena Kupcová Skalníková; Petr Vodička; Jan Motlík; Pavel Dundr; Karel Smetana; Ondřej Kodet
Journal:  Oncol Rep       Date:  2019-09-17       Impact factor: 3.906

Review 10.  Melanoma In Situ: A Critical Review and Re-Evaluation of Current Excision Margin Recommendations.

Authors:  Erica B Friedman; Richard A Scolyer; Gabrielle J Williams; John F Thompson
Journal:  Adv Ther       Date:  2021-05-28       Impact factor: 3.845
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.